BIOLINE RX LIMITED

Historical 13F Holders

Symbol
BLRX
CUSIP
09071M304
All holders as of
Q2 2026
Type
Equity
Class
SPONSORED ADR
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 09071M304 since 12/18/2024, largest first.

Filer % of Class Filed
Highbridge Capital Management, LLC 13G 7.2% 8/14/2025
Event 6/30/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 15 66.6 k $1.21 M
2026 Q1 14 19.6 k $45.2 k
2025 Q4 16 47.8 k $136 k
2025 Q3 15 27.7 k $104 k
2025 Q2 20 66.2 k $302 k
2025 Q1 13 9.46 k $28.0 k
2024 Q4 1 20.1 k $4.29 k